Immelmann A - Search Results

1

Lack of emergence of genotypic resistance to stavudine after 2 years of monotherapy.

Soriano V, Dietrich U, Villalba N, Immelmann A, Gil-Aguado A, Echevarría S, Clotet B, Ocaña I, Santamaría JM, Bouza E, Barona V, Gatell JM, González-Lahoz J. Soriano V, et al. Among authors: immelmann a. AIDS. 1997 Apr;11(5):696-7. AIDS. 1997. PMID: 9108961 No abstract available.

2

Genotypic and phenotypic resistance to stavudine after long-term monotherapy. BMS-020 Spanish Study Group.

Holguín A, Dietrich U, Immelmann A, Soriano V. Holguín A, et al. Among authors: immelmann a. Antivir Ther. 1998;3(3):183-6. Antivir Ther. 1998. PMID: 10682136 Clinical Trial.

3

Indication for increasing prevalence of resistance mutations for protease inhibitors in therapy-naive HIV-1-positive German patients.

Dietrich U, Raudonat I, Wolf E, Jäger H, Husak R, Orfanos CE, Knickmann M, Knechten H, von Briesen H, Ruppach H, Immelmann A. Dietrich U, et al. Among authors: immelmann a. AIDS. 1999 Nov 12;13(16):2304-5. doi: 10.1097/00002030-199911120-00014. AIDS. 1999. PMID: 10563717 No abstract available.

4

Resistance mutations selected in vivo under therapy with anti-HIV drug HBY 097 differ from resistance pattern selected in vitro.

Rübsamen-Waigmann H, Huguenel E, Shah A, Paessens A, Ruoff HJ, von Briesen H, Immelmann A, Dietrich U, Wainberg MA. Rübsamen-Waigmann H, et al. Among authors: immelmann a. Antiviral Res. 1999 May;42(1):15-24. doi: 10.1016/s0166-3542(99)00010-8. Antiviral Res. 1999. PMID: 10333139 Clinical Trial.

5

Molecular cloning of two west African human immunodeficiency virus type 2 isolates that replicate well in macrophages: a Gambian isolate, from a patient with neurologic acquired immunodeficiency syndrome, and a highly divergent Ghanian isolate.

Kühnel H, von Briesen H, Dietrich U, Adamski M, Mix D, Biesert L, Kreutz R, Immelmann A, Henco K, Meichsner C, et al. Kühnel H, et al. Among authors: immelmann a. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2383-7. doi: 10.1073/pnas.86.7.2383. Proc Natl Acad Sci U S A. 1989. PMID: 2467304 Free PMC article.

6

[Pyrido(3,2-e)(1,4)diazepines--synthesis and testing of anti-HIV-1 activity].

Görlitzer K, Wilpert C, Rübsamen-Waigmann H, Suhartono H, Wang L, Immelmann A. Görlitzer K, et al. Among authors: immelmann a. Arch Pharm (Weinheim). 1995 Mar;328(3):247-55. doi: 10.1002/ardp.19953280308. Arch Pharm (Weinheim). 1995. PMID: 7763140 German.

7

Detection of HIV RNA by in situ hybridization in peripheral blood mononuclear cells of seronegative children born to HIV-infected mothers.

Wahn V, Sauer S, Vollbach S, Immelmann A, Neumann B, Scheid A. Wahn V, et al. Among authors: immelmann a. Eur J Pediatr. 1990 Feb;149(5):330-2. doi: 10.1007/BF02171559. Eur J Pediatr. 1990. PMID: 2311629

8

Viral safety evaluation of biopharmaceuticals and homoeopathic preparations of human or animal origin.

Immelmann A. Immelmann A. Pharmeur Sci Notes. 2006 Aug;2006(1):41-5. Pharmeur Sci Notes. 2006. PMID: 17694646

9

Virus inactivation of plasma-derived proteins by pasteurization in the presence of guanidine hydrochloride.

Schlegel A, Immelmann A, Kempf C. Schlegel A, et al. Among authors: immelmann a. Transfusion. 2001 Mar;41(3):382-9. doi: 10.1046/j.1537-2995.2001.41030382.x. Transfusion. 2001. PMID: 11274595

10

Virus inactivation by pepsin treatment at pH 4 of IgG solutions: factors affecting the rate of virus inactivation.

Omar A, Kempf C, Immelmann A, Rentsch M, Morgenthaler JJ. Omar A, et al. Among authors: immelmann a. Transfusion. 1996 Oct;36(10):866-72. doi: 10.1046/j.1537-2995.1996.361097017171.x. Transfusion. 1996. PMID: 8863772

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters